News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Illinois Killer’s Extradition Pending with Missouri Governor

jail

A Missouri prosecutor says convicted Illinois killer Nicholas Sheley's extradition paperwork remains with Gov. Jay Nixon.

in Local

Wind Farm Could Be Headed to Logan County

wind turbine

$390 million project will bring renewable energy

in Local

Potential ALPLM Separation on Hold

Lincoln Presidential Museum

The chair of a state committee says lawmakers should wait for an outside study before considering plans to separate the Abraham Lincoln Presidential Library and Museum from a state agency.

in Local

Springfield Woman Faces More DUI Charges in Crash That Killed Two

ANDREA LITTLE 102052

Faces 11 counts in the deaths from a fatal October crash

in Local

Committee Hearings Begin on YWCA Block Redevelopment

4th and jackson

Two city blocks eyed for redevelopment